Correspondence 0001104659-24-003909 from GridAI Technologies Corp. (GRDX)
GridAI Technologies Corp.
Date: Jan. 16, 2024 · CIK: 0001604191 · Accession: 0001104659-24-003909
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-276429
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences Attention: Jessica Dickerson Re: First Wave BioPharma, Inc. (the “Company”) Registration Statement on Form S-3 Filed on January 8, 2024 File No. 333-276429
Dear Ms. Dickerson:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 5:00 p.m. ET on January 17, 2024, or as soon as thereafter practicable.
Please call Jessica Yuan of Ellenoff Grossman & Schole LLP at 212-370-1300 to confirm the effectiveness of the Registration Statement or with any questions.
Very truly yours,
/s/ Sarah Romano
Show Raw Text
CORRESP
1
filename1.htm
First Wave BioPharma, Inc.
777 Yamato Road, Suite 502
Boca Raton, Florida 33431
January 16, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jessica Dickerson
Re:
First Wave BioPharma, Inc. (the “Company”)
Registration Statement on Form S-3
Filed on January 8, 2024
File No. 333-276429
Dear Ms. Dickerson:
Pursuant to Rule 461 under
the Securities Act of 1933, as amended, the Company hereby requests acceleration of effectiveness of the above referenced Registration
Statement so that it will become effective at 5:00 p.m. ET on January 17, 2024, or as soon as thereafter practicable.
Please call Jessica Yuan
of Ellenoff Grossman & Schole LLP at 212-370-1300 to confirm the effectiveness of the Registration Statement or with any questions.
Very truly yours,
/s/ Sarah Romano
Sarah Romano
Chief Financial Officer
cc:
Ellenoff Grossman & Schole LLP